3138 results for «878»
3138 results
Contemporary TAVI cases: perspectives from three different continents
16 May 2024 – From EuroPCR 2024
This session provides perspectives from three different continents on the management of complex TAVI cases. It features case presentations and discussions on topics such as TAVR for the correction of aortic pseudoaneurysm, TAV-in-TAV intervention, and the management of aortic stenosis in patients with hypertrophic obstructive cardiomyopathy....
Bridging perspectives: bifurcation lesions - A global case exploration
16 May 2024 – From EuroPCR 2024
This session explores the management of bifurcation lesions from a global perspective, featuring case studies and discussions from experts in various regions. The session covers topics such as when to use two stents for bifurcation lesions, techniques for managing complicated Medina 0,0,1 bifurcation lesions, and the...
Challenging LAA occlusion cases
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios in left atrial appendage (LAA) occlusion procedures. Participants will learn about techniques for rescuing a migrating LAA occluder, managing incomplete surgical LAA ligation, and utilizing specialized techniques like the "kissing" approach for LAA...
Innovative approaches to rare PCI complications in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex PCI scenarios in NSTEMI patients. Participants will learn about rare complications following coronary angioplasty, strategies for identifying the correct culprit lesion, techniques for managing pericardial effusion, and other challenging situations encountered during complex PCI in NSTEMI....
Complications in CTO: is there a bailout?
16 May 2024 – From EuroPCR 2024
Watch this session on CTO complications and explore unique challenges and solutions, including a retrograde CTO technique with a twist, an unexpected outcome in a right coronary artery case, and an atypical perforation caused by an unexpected equipment issue. You’ll also see how a guide wire...
Vulnerable plaque identification and treatment
16 May 2024 – From EuroPCR 2024
This session focuses on the role of non-invasive and intra-coronary imaging in the identification and management of vulnerable plaque. Participants will explore the use of CCTA and intracoronary imaging techniques, such as IVUS, to diagnose vulnerable atherosclerosis. The session also evaluates the evidence supporting conservative or...
Challenges and complications in STEMI: resuscitated cardiac arrest, left ventricular free wall rupture & more!
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging and complex STEMI cases, highlighting the various complications that can arise during primary PCI. Attendees will witness real-life scenarios, including resuscitated cardiac arrest, the use of rotational atherectomy, left ventricular free wall rupture, and more. Through interactive discussions, the...
Management of LAA closure complications
16 May 2024 – From EuroPCR 2024
This session explores the various complications that can arise during left atrial appendage (LAA) closure procedures, including pericardial effusion, device embolisation, and procedural strokes. Learn how to identify risk factors, prevent these complications, and effectively manage them through case-based discussions and expert guidance.
PCI of calcified lesions
16 May 2024 – From EuroPCR 2024
This session delves into the treatment of calcified lesions, providing a comprehensive overview of contemporary tools and techniques for optimal plaque modification. Attendees will learn through a series of case presentations, where experts dissect challenging cases involving severe coronary calcification, including in the left main trunk....
State-of-the-art on left main interventions in Latin America
16 May 2024 – From EuroPCR 2024
This session, in collaboration with the Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI), provides insights into the management of left main coronary artery disease in Latin America. Attendees will learn about the revascularization guidelines for left main in the region, the approaches to left main bifurcations...
How to treat my patient with secondary mitral regurgitation
20 Nov 2023 – From PCR London Valves 2023
How is secondary mitral regurgitation classified? How to choose between surgical and transcatheter intervention? How to determine the best transcatheter treatment option? Watch the debates sparked by the case studies presented in this PCR London Valves 2023 session to find out.
Welcome to GulfPCR Valves 2023
05 Dec 2023 – From GulfPCR-GIM 2023
Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...
TAVI for bicuspid aortic stenosis patients - Recorded cases
05 Dec 2023 – From GulfPCR-GIM 2023
Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.
- An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI and access: alternating is wise
16 Jan 2024 – From GulfPCR-GIM 2023
Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...
Newer generation self-expanding platform: technical optimisation for common clinical challenges
05 Dec 2023 – From GulfPCR-GIM 2023
The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...
TAVI step by step
19 Nov 2023 – From PCR London Valves 2023
Watch this interactive session to get tips and tricks to solve the technical difficulties that can come up during a TAVI, and learn more about mastering CT imaging for successful TAVI planning, understanding valve selection principles, and refining TAVI procedures for improved efficiency and technique.
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...
Challenging TAVI cases
19 Nov 2023 – From PCR London Valves 2023
This PCR London Valves 2023 session aims to analyse some of the complex aspects of TAVI by looking at challenging clinical and anatomical scenarios to enable you to learn how to manage potential complications by learning about innovative strategies and exploring different approaches.
Planning and execution of re-do TAVI (TAV-in-TAV) procedures
19 Nov 2023 – From PCR London Valves 2023
Redo TAVI poses challenges but can be managed with a step-by-step procedural plan, ensuring better acute and long-term outcomes. Guidelines and industry resources aid in planning, yet forthcoming registry studies are essential for further data and insights. Watch this session to find out more!
Evidence gap and new indications
05 Dec 2023 – From GulfPCR-GIM 2023
Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...
